跳至主要内容
临床试验/IRCT20200218046533N1
IRCT20200218046533N1招募中2 期

The Evaluation of the Efficacy of Calcitriol Compared to Calcitriol plus Cinacalcet in the Treatment of Severe Secondary Hyperparathyroidism in Hemodialysis Patients Referred to Dialysis Centers in Gorgan

Gorgan University of Medical Sciences0 个研究点目标入组 70 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 85 years(—)
性别
All

入选标准

  • Aged 18 years and more;
  • Dialysis for at least 3 months;
  • iPTH levels above 800 pg/dL (severe secondary hyperparathyroidism);
  • Do not take medications that have drug interactions such as flecainide, thioridazine, tricyclic antidepressants due to the effect of Cinacalcet on the P-450 cytochrome;
  • No hypersensitivity reaction to the drugs used in the study;
  • No liver disease;
  • Calcium levels > 8.4 mg/dL.

排除标准

  • Any evidence of cancer in different parts of the body;
  • Side effects of the medications used during the study period;
  • Diseases causing hypercalcemia;
  • History of parathyroidctomy;
  • Presence of parathyroid adenoma (to be confirmed by parathyroid scan);
  • Pregnant mothers or lactating women or females of childbearing age who do not currently use contraception.

研究者

发起方
Gorgan University of Medical Sciences

相似试验